๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

โœ Scribed by Estanga, A.; Rodriguez-Oroz, M.C.; Ruiz-Martinez, J.; Barandiaran, M.; Gorostidi, A.; Bergareche, A.; Mondragon, E.; Lopez de Munain, A.; Marti-Masso, J.F.

Book ID
127328250
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
324 KB
Volume
20
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neuropathology of Parkinson's disease wi
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
โœ Josรฉ-Fรฉlix Martรญ-Massรณ; Javier Ruiz-Martรญnez; Maria J. Bolaรฑo; Irune Ruiz; Ana G ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 348 KB

## Abstract We report the neuropathological findings in a patient with Parkinson's disease (PD) associated with Basque R1441Gโ€__LRRK2__/dardarin mutation. The patient was a man with disease onset at 68 years of age, with unilateral rest tremor; the Parkinsonism was well controlled with medication f

Penetrance in Parkinson's disease relate
Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain)
โœ Javier Ruiz-Martรญnez; Ana Gorostidi; Berta Ibaรฑez; Ainhoa Alzualde; David Otaegu ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB

## Abstract The __LRRK2 R1441G__ mutation was first identified in Basque families and it is responsible for 46% of familial Parkinson's disease (PD) and for 2.5% of sporadic PD in the PD population of Basque ascent. The aim of this study was to determine __LRRK2 R1441G__ penetrance in PD in the Bas

Olfactory deficits and cardiac 123I-MIBG
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations
โœ Javier Ruiz-Martรญnez; Ana Gorostidi; Estibaliz Goyenechea; Ainhoa Alzualde; Juan ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB

## Abstract It has been proposed that olfactory tests and metaiodobenzylguanidine cardiac scintigraphy may help diagnose idiopathic Parkinson's disease in the premotor phase. However, it is not clear what value these tests have in all patients with Parkinson's disease and, particularly, in those wh